Influence of Platelet Concentrates on Wound Healing

NCT03667638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-09-12

No results posted yet for this study

Summary

Chronic soft tissues defects can extend into the fat layer or even deeper and can cause functional disadvantages. Split-thickness skin grafts (STSGs) used to cover these wounds have varying success rates. To improve wound healing in chronic wounds the authors have studied the application of autologous platelet concentrates in a human keratinocyte culture model in vitro and in a combination with surgical procedures in vivo as second line therapy in patients with initially failed wound closure.

Conditions

  • Platelet-Rich Plasma
  • Wound Healing Delayed

Interventions

COMBINATION_PRODUCT

Platelet-Rich Plasma

Adding PRP to wound bed during surgical debridement

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Peter Vogt, MD · Medical School Hannover

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667638 on ClinicalTrials.gov